Illinois Business Review
SEE OTHER BRANDS

Your business and economy news reporter from Illinois

Illinois Business Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Illinois Business Review.

Press releases published on April 23, 2025

Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses

Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses

SAN CARLOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …

Zeneara Under Review: Natural Mute Button Method Helps Silence Tinnitus Ringing

Zeneara Under Review: Natural Mute Button Method Helps Silence Tinnitus Ringing

New York City, April 23, 2025 (GLOBE NEWSWIRE) -- Introduction: The Silent Struggle with Tinnitus The Unseen Burden Millions Carry Tinnitus, commonly described as a persistent ringing, buzzing, or hissing sound in the ears, is more than just an annoyance— …

Silvaco Announces Date of First Quarter 2025 Financial Results Conference Call

Silvaco Announces Date of First Quarter 2025 Financial Results Conference Call

SANTA CLARA, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (Nasdaq: SVCO, “Silvaco”), a provider of TCAD, EDA software, and SIP solutions that enable innovative semiconductor design and digital twin modeling through AI software and …

John B. Sanfilippo & Son, Inc. 3rd Quarter Fiscal Year 2025 Operating Results Conference Call

John B. Sanfilippo & Son, Inc. 3rd Quarter Fiscal Year 2025 Operating Results Conference Call

Elgin, IL, April 23, 2025 (GLOBE NEWSWIRE) -- John B. Sanfilippo …

Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025

Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025

Data from Cohorts 1-3 of trial to be presented in an oral session and poster at the Society for Investigative Dermatology (SID) 2025 Annual Meeting Company to discuss data on its first quarter 2025 business update conference call and webcast scheduled for …

Brookline Bancorp Announces First Quarter Results

Brookline Bancorp Announces First Quarter Results

Net Income of $19.1 million, EPS of $0.21 Operating Earnings of $20.0 million, Operating EPS of $0.22 Quarterly Dividend of $0.135 BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Brookline Bancorp, Inc. (NASDAQ: BRKL) (the “Company”) today announced net income …

Remitly to Report First Quarter Financial Results on May 7, 2025

Remitly to Report First Quarter Financial Results on May 7, 2025

SEATTLE, April 23, 2025 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of digital financial services that transcend borders, today announced that it will report first quarter financial results after the market close …

Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025

Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025

SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …

 ACV to Report First Quarter 2025 Financial Results on May 7, 2025

ACV to Report First Quarter 2025 Financial Results on May 7, 2025

BUFFALO, N.Y., April 23, 2025 (GLOBE NEWSWIRE) -- ACV (NYSE: ACVA), a leading digital automotive marketplace and data services partner for dealers and commercial clients, announced today that the Company will report first quarter 2025 financial results …

OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th

OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th

BETHLEHEM, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2025 financial results and certain business developments for 5 p.m. ET on May 7, 2025. A …

Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025

Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025

WEST LAFAYETTE, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research …

Dynagas LNG Partners LP Declares Cash Distribution on Its Series A Preferred Units

Dynagas LNG Partners LP Declares Cash Distribution on Its Series A Preferred Units

ATHENS, Greece, April 23, 2025 (GLOBE NEWSWIRE) -- Dynagas LNG Partners LP (the “Partnership”) (NYSE: “DLNG”), an owner and operator of LNG carriers, today announced that its Board of Directors has declared a cash distribution of $0.5625 per unit on its …

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on January 31, 2025, the company issued inducement awards …

TFI International Announces 2025 First Quarter Results

TFI International Announces 2025 First Quarter Results

First quarter operating income of $114.6 million compares to $151.6 million in the same prior year quarter First quarter net income of $56.0 million compares to $92.8 million in Q1 2024, while adjusted net income1 of $64.2 million compares to $105.5 …

RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025

RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025

ALISO VIEJO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results for the …

Beyond Meat® to Report First Quarter 2025 Financial Results on May 7, 2025

Beyond Meat® to Report First Quarter 2025 Financial Results on May 7, 2025

EL SEGUNDO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or “the Company”), a leader in plant-based meat, announced today it will report financial results for the first quarter ended March 29, 2025 on Wednesday …

Sight Sciences Announces the Release of its Sustainability Report

Sight Sciences Announces the Release of its Sustainability Report

MENLO PARK, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today …

Dragonfly Energy Announces First Quarter 2025 Preliminary Net Sales and Adjusted EBITDA

Dragonfly Energy Announces First Quarter 2025 Preliminary Net Sales and Adjusted EBITDA

RENO, Nev., April 23, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), an industry leader in energy storage and battery technology, today announced preliminary first quarter 2025 Net Sales and …

OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025

OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025

WARSAW, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service